ArticleCardiovascular diagnosis and therapy2019
Interact, engage or partner? Working with the private sector for the prevention and control of noncommunicable diseases.
Article in Cardiovascular diagnosis and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Defining the commercial determinants of health: a systematic review.BMC public health · 2020Pooled it
- Perspectives on cardiovascular longevity and economic prosperity in the Association of Southeast Asian Nations (ASEAN).npj aging · 2026Article
- Private sector engagement strategies with implications for NCD prevention and control: focus on ten international organisations.Global health research and policy · 2025Article
- Managing engagement among public, private and civil society actors participating in NewTools: a research partnership on food profiling.Public health nutrition · 2025Article
- World health Organization's guidance for tracking non-communicable diseases towards sustainable development goals 3.4: an initiative for facility-based monitoring.EClinicalMedicine · 2025Article
- Reflections on Corporate Political Activity Taxonomies in the Context of Non-communicable Diseases and Mental Health Comment on "Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy".International journal of health policy and management · 2025Article
- Investing in Addressing NCDs and Mental Health Conditions: a Political Choice.Annals of global health · 2025Article
- Governing Political Realities in NCD Agenda Setting in LMICS: a Case of the Carrot and the Stick?; Comment on "National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries: a Scoping Review and Framework Synthesis".International journal of health policy and management · 2024Article
- Multisectoral action to address noncommunicable diseases: lessons from three country case studies.Frontiers in public health · 2024Review
- National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries - A Scoping Review and Framework Synthesis.International journal of health policy and management · 2023Article
- Engaging with the Private Sector for Noncommunicable Disease Prevention and Control: Is it Possible to Create "Shared Value?"Annals of global health · 2023Article
- Governing industry involvement in the non-communicable disease response in Kenya.Globalization and health · 2021Article
- Gaining a deeper understanding of nutrition using social networks and user-generated content.Internet interventions · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Noncommunicable diseases (NCDs), including cardiovascular diseases (CVDs), cancers, chronic respiratory diseases and diabetes, account for 72% of all global deaths, with 78% of all NCDs taking place in low- and middle-income countries. Among these four main groups of NCDs, CVDs are taking the highest death toll at 17.9 million or 44% of all NCD mortality. This paper suggests that the complex interplay of NCD risk factors and their underlying social and commercial determinants requires active cooperation with the private sector to bring about policy change, pool resources and generate innovative solutions by capitalizing on each partner's strengths. However, such partnerships can only be successful if safeguards are in place to define the rules of engagement, align incentives to achieve shared public health objectives and manage potential conflicts of interest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.